Embecta (EMBC) Retained Earnings (2021 - 2026)
Embecta (EMBC) reported Retained Earnings of -$290.0 million for Q1 2026, down 546.15% on a YoY basis from $65.0 million in Q1 2025, and down 454.52% sequentially from $81.8 million in Q4 2025.
Embecta (EMBC) Retained Earnings (2021 - 2026) Analysis & Trends
Embecta (EMBC) has 6 years of Retained Earnings data on file, last reported at -$290.0 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 546.15% year-over-year to -$290.0 million; the trailing twelve-month figure through Mar 2026 stood at -$290.0 million (down 546.15% YoY), and the FY2025 full-year result was -$445.6 million, up 10.63% from the prior year.
- Retained Earnings eased to -$290.0 million in Q1 2026, from $81.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $81.8 million in Q4 2025 to a low of -$541.1 million in Q3 2023.
- A 5-year average of -$229.8 million and a median of -$290.0 million in 2026 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slumped 5511.0% in 2023 and surged 116.11% in 2025, its largest moves.
- Tracing EMBC's Retained Earnings over 5 years: stood at -$298.9 million in 2022, then slumped by 77.32% to -$530.0 million in 2023, then increased by 4.17% to -$507.9 million in 2024, then surged by 116.11% to $81.8 million in 2025, then tumbled by 454.52% to -$290.0 million in 2026.
- Business Quant data shows EMBC's Retained Earnings at -$290.0 million in Q1 2026, $81.8 million in Q4 2025, and -$445.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 22.11 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -1.76 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 122.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -24.91 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.98 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 1.81 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.55 Bn |
| 10 | Embecta | 192.72 Mn | -678,250.00 | 127.80 Mn | -290.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -290.00 Mn |
| Dec 31, 2025 | 81.80 Mn |
| Sep 30, 2025 | -445.60 Mn |
| Jun 30, 2025 | 70.20 Mn |
| Mar 31, 2025 | 65.00 Mn |
| Dec 31, 2024 | -507.90 Mn |
| Sep 30, 2024 | -498.60 Mn |
| Jun 30, 2024 | 46.20 Mn |
| Mar 31, 2024 | -510.00 Mn |
| Dec 31, 2023 | -530.00 Mn |
| Sep 30, 2023 | -541.10 Mn |
| Jun 30, 2023 | -294.70 Mn |
| Mar 31, 2023 | 18.10 Mn |
| Dec 31, 2022 | -298.90 Mn |
| Sep 30, 2022 | 10.00 Mn |
| Jun 30, 2022 | 5.80 Mn |
| Mar 31, 2022 | -286.40 Mn |
| Dec 31, 2021 | -279.30 Mn |
| Sep 30, 2021 | -270.50 Mn |